You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 3, March 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (110)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Psoriasis Induced at the Injection Site of Recombinant Interferon Gamma

Results of Immunohistologic Investigations

Gerhard Fierlbeck, MD; Gernot Rassner, MD; Claudia Müller, MD

Arch Dermatol. 1990;126(3):351-355.


Abstract

• Recombinant human interferon gamma used for treatment of psoriatic arthritis was found to induce expression of HLA-DR, but not HLA-DP or HLA-DQ, on keratinocytes at the site of injection. Some patients showed an improvement of their joint symptoms, but the cutaneous manifestations remained unaffected. In 10 of 42 patients, punctiform psoriatic foci could be induced at the site of injection of interferon gamma. For this presentation, we selected a female patient with psoriatic arthropathy and type II diabetes mellitus in whom psoriasis was induced at the site of application of interferon gamma, but not after subcutaneous injection of insulin or placebo. We conclude that interferon gamma is an important lymphokine in the development of psoriasis.

(Arch Dermatol. 1990;126:351-355)



Author Affiliations

From the Dermatology Division (Drs Fierlbeck and Rassner) and Medical Division, Department II (Dr Müller), University of Tübingen (West Germany).


Footnotes

Accepted for publication September 25, 1989.

Reprint requests to Universitäts-Hautklinik, Liebermeisterstrasse 25, D-7400 Tübingen, West Germany (Dr Fierlbeck).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Overexpression of CD1d by Keratinocytes in Psoriasis and CD1d-Dependent IFN-{gamma} Production by NK-T Cells
Bonish et al.
J. Immunol. 2000;165:4076-4085.
ABSTRACT | FULL TEXT  

Response of keratinocytes from normal and psoriatic epidermis to interferon-{gamma} differs in the expression of zinc-{alpha}2-glycoprotein and cathepsin D
CHEN et al.
FASEB J. 2000;14:565-571.
ABSTRACT | FULL TEXT  

The Immunologic and Genetic Basis of Psoriasis
Nickoloff
Arch Dermatol 1999;135:1104-1110.
FULL TEXT  

Response of Murine and Normal Human Skin to Injection of Allogeneic Blood-Derived Psoriatic Immunocytes: Detection of T Cells Expressing Receptors Typically Present on Natural Killer Cells, Including CD94, CD158, and CD161
Nickoloff et al.
Arch Dermatol 1999;135:546-552.
ABSTRACT | FULL TEXT  

Psoriatic keratinocytes show reduced IRF-1 and STAT-1{alpha} activation in response to {gamma}-IFN
JACKSON et al.
FASEB J. 1999;13:495-502.
ABSTRACT | FULL TEXT  

Interactions Between Non-Immune Host Cells and the Immune System During Periodontal Disease: Role of the Gingival Keratinocyte
Suchett-Kaye et al.
CROBM 1998;9:292-305.
ABSTRACT | FULL TEXT  

T-Cell Activation Is Potentiated by Cytokines Released by Lesional Psoriatic, but Not Normal, Epidermis
Chang et al.
Arch Dermatol 1992;128:1479-1485.
ABSTRACT  

Interleukin 1{alpha}, Tumor Necrosis Factor {alpha}, and Interferon {gamma} in Psoriasis
Gomi et al.
Arch Dermatol 1991;127:827-830.
ABSTRACT  

Psoriasis With Articular Involvement Induced by Interferon Alfa
Jucgla et al.
Arch Dermatol 1991;127:910-911.
ABSTRACT  

Psoriasis Induced at the Injection Site of Recombinant Interferons
Kowalzick and Weyer
Arch Dermatol 1990;126:1515-1516.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.